Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

HY Na, HW Yu, W Kim, JH Moon, CH Ahn… - Clinical …, 2022 - Wiley Online Library
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …
被引用次数：10 相关文章

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma.

HY Na, HW Yu, W Kim, JH Moon, CH Ahn… - Clinical …, 2022 - europepmc.org
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

HY Na, HW Yu, W Kim, JH Moon, CH Ahn… - Clinical …, 2022 - s-space.snu.ac.kr
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

HY Na, HW Yu, W Kim, JH Moon… - Clinical …, 2022 - snucm.elsevierpure.com
Objective: Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

HY Na, HW Yu, W Kim, JH Moon, CH Ahn, SI Choi… - Clinical …, 2022 - infona.pl
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

HY Na, HW Yu, W Kim, JH Moon… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma.

HY Na, HW Yu, W Kim, JH Moon… - Clinical …, 2022 - search.ebscohost.com
Objective: Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …